Diovan (Blood Pressure Drug) Cuts Risk of Diabetes, Especially in High-Risk GroupMay 18th, 2005 Valsartan, commercially known as Diovan, a drug that controls blood pressure and reduces heart risk, also appears to protect against diabetes, especially in high-risk people, according to new research presented at the American Society of Hypertension's Twentieth Annual Scientific Meeting and Exposition (ASH 2005) by a University of Michigan physician who helped lead the study. The randomized trial involved 15,313 patients at 942 sites in 31 countries, of whom 9,995 did not have diabetes at the start of the study.
Gene expression inhibitor drug made mice (STZ induced) diabetes resistantMarch 21st, 2005 Researchers from North Shore-Long Island Jewish Health System in Manhasset, N.Y. have identified a gene which expresses as a protein called macrophage migration inhibitory factor, or MIF.
Ruboxistaurin (RBX) May Reduce Risk of Vision Loss in DiabeticsJuly 16th, 2005 A multicenter international study chaired by a Joslin Diabetes Center investigator and reported in the July issue of the American Diabetes Association’s journal Diabetes brings hopeful news to the 18 million people in the United States -- and millions more worldwide -- with type 1 or type 2 diabetes. Initial results of the Phase III clinical trial demonstrated that 32 milligrams per day of ruboxistaurin (RBX) was well tolerated and may reduce the risk of moderate vision loss, especially in patients with diabetic macular edema.
Diabetes Cure PossibleJune 18th, 2006 Cure for diabetes could be around the corner after US scientists found cells from the spleen can transform into insulin-producing cells. US researchers were able to halt, and even reverse, the disease in mice.
Type 1 diabetics required for "ground-breaking" vision studyApril 13th, 2005 OPTOMETRY researchers at Aston University’s new £10 million Academy of Life Sciences are currently undertaking ground-breaking research into the vision problems caused by diabetics – one of the leading causes of blindness and vision loss in the UK. So far, the study has been very successful with a large number of diabetic volunteers stepping forward to take part in the study, but the researchers still require some more Type 1 diabetics (insulin dependent patients usually diagnosed under the age of 30) in order to obtain reliable results.
Volunteers Needed for Inhaled Insulin StudyJuly 27th, 2005 Researchers at Indiana University School of Medicine are looking for 400 people with type 1 diabetes to volunteer for a study of an inhaled insulin treatment. The Indiana University School of Medicine is one of 70 sites around the world testing the treatment developed by Indianapolis-based Eli Lilly and Co.
The Diabetes Blog - Marching towards a cureMay 22nd, 2005 Simple Thoughts is an aggregation of several member blogs like The Diabetes Blog, The Java Software Blog etc. Each of the blogs are unique in focus and content, except aggregation blogs like The Health Blog or The Technology Blog.
Joslin Researcher's find genetic defects leading to auto-immune attack on pancreasMarch 23rd, 2005 Scientists at Joslin Diabetes Center have found genetic regions that, when defective, allow the immune system to attack the pancreas - the first in a series of mis-steps that lead to type 1 diabetes. Armed with these findings, published today, March 22, in the journal Immunity, the researchers are now trying to hone in on the exact genes involved, in mice and in human patients.
FDA OK's Cholesterol Drug Lipitor for DiabeticsSeptember 27th, 2005 Pfizer Inc. said U.S. regulators (FDA) have approved its cholesterol lowering drug Lipitor. Lipitor is used to reduce the risk of stroke and heart attack in diabetic patients.
Pizza's are Bad News for DiabeticsJuly 17th, 2005 "Keeping glucose levels from jumping too high or dipping too low may help to reduce the risk of cardiovascular disease, which has been connected to erratic glucose levels in those with diabetes," said Robert Gabbay, MD, Ph.D., associate professor of medicine, Penn State College of Medicine, Penn State Milton S. Hershey Medical Centre, and co-director, Penn State Diabetes Centre.
Immune System re-education may be the best hope for diabetes cureMarch 14th, 2005 A discussion on immune system re-education results.
Diabetes Treatment by Consuming TeaAugust 9th, 2005 Study conducted by researchers at the University of Scranton suggests that tea might prevent diabetes and its associated complications, including diabetic cataracts. Researchers led by Joe Vinson fed green and black tea to diabetic rats for three months and then monitored the chemical composition of the rats' blood and eye lenses.
Research indicates waist circumference is the strongest indicator of type 2 diabetes risk in menApril 2nd, 2005 According to the team, as waist circumference increased, so did the risk of developing diabetes, with the risk in men with the highest waist circumference (up to 158 centimeters) increasing by 12-fold, they report. "Our findings support the contention that the measurement of waist circumference should be used in clinical practice instead of waist-to-hip ratio," the investigators write.
Link between Fat Tissue and Diabetes DiscoveredAugust 9th, 2005 Overweight or obese has long been recognized as a risk factor for type 2 diabetes. The results of a new study are clarifying the nature of the link between weight and diabetes.
AIIMS / Indian Government Ideal For DCA Human Trial For Cancer TreatmentFebruary 5th, 2007 India is the ideal place to conduct human trial for the effectiveness of DCA ( dichloroacetate ) as anti-cancer drug. The government regulations for human trial aren't as stringest as USA, there are funds available for such studies and frankly you don't need much.
Comment Below | 
Email this Article
Loading ...